Gout
Conditions
Interventions
Group A:stepwise dose increase of febuxostat
Group B:febuxostat+colchicine
Group C:febuxostat40mg/d
Sponsors
Anqing Hospital Affiliated to Anhui Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. All enrolled patients met the 1977 American college of rheumatology (ACR) gout classification criteria and/or the 2015 ACR gout classification criteria; 2. It is developed gout flares at least once in the previous year; 3. Serum uric acid >7.0mg/dl (420umol/L); 4. At least 1 month before entering the study, no uricate-lowering drugs were given; 5. Included in the study with written informed consent.
Exclusion criteria
Exclusion criteria: 1. Aged 2.0mg/dL (177umol/L); 4. Those with severe comorbid conditions and those whom the researchers judged to be unsuitable candidates for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood uric acid; | — |
Countries
China
Contacts
Public ContactGuihong Wang
Department of Rheumatology, Anqing Hospital Affiliated to Anhui Medical University
Outcome results
None listed